Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters

被引:97
|
作者
Kaihatsu, Kunihiro [1 ]
Yamabe, Miyuki [1 ]
Ebara, Yasuhito [1 ]
机构
[1] Kobe Univ, Grad Sch Human Dev & Environm, 3-11 Tsurukabuto, Kobe, Hyogo 6578501, Japan
来源
MOLECULES | 2018年 / 23卷 / 10期
关键词
catechin; epigallocatechin-3-O-gallate; virus inhibition; attachment; entry; fusion; replication; budding; fatty acid derivative; GREEN TEA POLYPHENOL; SIMPLEX-VIRUS TYPE-1; INFLUENZA-VIRUS; ANTIINFLUENZA VIRUS; GALLATE; INHIBITION; CATECHIN; EGCG; DERIVATIVES; ENTRY;
D O I
10.3390/molecules23102475
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epigallocatechin-3-O-gallate (EGCG) is the major catechin component of green tea (Cameria sinensis), and is known to possess antiviral activities against a wide range of DNA viruses and RNA viruses. However, few studies have examined chemical modifications of EGCG in terms of enhanced antiviral efficacy. This paper discusses which steps of virus infection EGCG interferes with, citing previous reports. EGCG appears most likely to inhibits the early stage of infections, such as attachment, entry, and membrane fusion, by interfering with viral membrane proteins. According to the relationships between structure and antiviral activity of catechin derivatives, the 3-galloyl and 5'-OH group of catechin derivatives appear critical to antiviral activities. Enhancing the binding affinity of EGCG to virus particles would thus be important to increase virucidal activity. We propose a newly developed EGCG-fatty acid derivative in which the fatty acid on the phenolic hydroxyl group would be expected to increase viral and cellular membrane permeability. EGCG-fatty acid monoesters showed improved antiviral activities against different types of viruses, probably due to their increased affinity for virus and cellular membranes. Our study promotes the application of EGCG-fatty acid derivatives for the prevention and treatment of viral infections.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] ANTITUMOR ACTIVITY OF (-)-EPIGALLOCATECHIN-3-O-GALLATE FATTY ACID DERIVATIVES
    Kaihatsu, Kunihiro
    Matsumura, Kazuaki
    Mori, Shuichi
    Cho, Han Hee
    Hyon, Suong Hyu
    Kato, Nobuo
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3338 - 3338
  • [2] Oligomerization mechanism of epigallocatechin-3-O-gallate during autoxidation
    Matsuo, Yosuke
    Katayama, Kohei
    Yamashita, Takako
    Saito, Yoshinori
    Tanaka, Takashi
    FOOD CHEMISTRY, 2024, 449
  • [3] Enhanced antitumor activities of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives in vitro and in vivo
    Matsumura, Kazuaki
    Kaihatsu, Kunihiro
    Mori, Shuichi
    Cho, Han Hee
    Kato, Nobuo
    Hyon, Suong Hyu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 377 (04) : 1118 - 1122
  • [4] Anti-influenza A virus inhibitory effect of (-)- epigallocatechin-3-O-gallate fatty acid monoester derivatives
    Kaihatsu, Kunihiro
    Mori, Shuichi
    Kato, Nobuo
    ANTIVIRAL RESEARCH, 2008, 78 (02) : A41 - A41
  • [5] Epigallocatechin-3-O-gallate inhibits fibroblast contraction of floating collagen gel:: Interaction between epigallocatechin-3-O-gallate and platelet derived growth factor
    Suzuki, Y
    Hattori, S
    Isemura, M
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2004, 68 (08) : 1817 - 1820
  • [6] Preservation of Platelets by Adding Epigallocatechin-3-O-Gallate to Platelet Concentrates
    Matsumura, Kazuaki
    Takayama, Hiroshi
    Bae, Jung Yoon
    Kurihara, Mitsuru
    Tsutsumi, Sadami
    Hyon, Suong-Hyu
    CELL TRANSPLANTATION, 2009, 18 (5-6) : 521 - 528
  • [7] Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases
    Fukutomi, Ryuuta
    Ohishi, Tomokazu
    Koyama, Yu
    Pervin, Monira
    Nakamura, Yoriyuki
    Isemura, Mamoru
    MOLECULES, 2021, 26 (02):
  • [8] Properties of Precipitate of Creaming Down by (-)-Epigallocatechin-3-O-gallate and Caffeine
    Ishizu, Takashi
    Tsutsumi, Hiroyuki
    Kinoshita, Yoshifumi
    Mukaida, Hironori
    Sato, Takashi
    Kajitani, Shinya
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2014, 62 (06) : 552 - 558
  • [9] Hibernation, reversible cell growth inhibition by epigallocatechin-3-O-gallate
    Matsumura, Kazuaki
    Kim, Jong-Yoon
    Tsutsumi, Sadami
    Hyon, Suong-Hyu
    JOURNAL OF BIOTECHNOLOGY, 2007, 127 (04) : 758 - 764
  • [10] Epigallocatechin-3-O-gallate induces acid sphingomyelinase activation through activation of phospholipase C
    Bae, Jaehoon
    Kumazoe, Motofumi
    Takeuchi, Chieri
    Hidaka, Shiori
    Fujimura, Yoshinori
    Tachibana, Hirofumi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 520 (01) : 186 - 191